Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Development ; 125(7): 1315-24, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9477330

RESUMEN

Mesenchymal-epithelial tissue interactions are important for development of various organs, and in many cases, soluble signaling molecules may be involved in this interaction. Hepatocyte growth factor (HGF) is a mesenchyme-derived factor which has mitogenic, motogenic and morphogenic activities on various types of epithelial cells and is considered to be a possible mediator of epithelial-mesenchymal interaction during organogenesis and organ regeneration. In this study, we examined the role of HGF during lung development. In situ hybridization analysis showed HGF and the c-met/HGF receptor gene to be respectively expressed in mesenchyme and epithelium in the developing lung. In organ cultures, exogenously added HGF apparently stimulated branching morphogenesis of the fetal lung. In contrast, HGF translation arrest or neutralization assays resulted in clear inhibition of epithelial branching. These results suggest that HGF is a putative candidate for a mesenchyme-derived morphogen regulating lung organogenesis. We also found that HGF is involved in epithelial branching, in collaboration with fibroblast growth factor (FGF) family molecule(s). In mesenchyme-free culture, HGF alone did not induce epithelial morphogenesis, however, addition of both HGF and acidic FGF (aFGF) or keratinocyte growth factor (KGF), ligands for the KGF receptor, induced epithelial branching more extensively than that was observed in explants treated with aFGF or KGF alone. In addition, the simultaneous inhibition of HGF- and FGF-mediated signaling using neutralizing antibody and antisense oligo-DNA resulted in drastic impairment of epithelial growth and branching. Possible interactions between HGF and FGFs or other growth factors in lung development is given consideration.


Asunto(s)
Regulación del Desarrollo de la Expresión Génica/genética , Factor de Crecimiento de Hepatocito/fisiología , Pulmón/crecimiento & desarrollo , Animales , Anticuerpos/inmunología , Anticuerpos/farmacología , Citocinas/fisiología , Desarrollo Embrionario y Fetal/fisiología , Factor 1 de Crecimiento de Fibroblastos , Factor de Crecimiento de Hepatocito/farmacología , Hibridación in Situ , Pulmón/citología , Pulmón/embriología , Mesodermo/química , Morfogénesis/fisiología , Oligonucleótidos Antisentido/genética , Oligonucleótidos Antisentido/farmacología , Técnicas de Cultivo de Órganos , Proteínas Proto-Oncogénicas c-met/metabolismo , ARN Mensajero/análisis , Ratas , Ratas Wistar , Proteínas Recombinantes/farmacología
2.
J Cereb Blood Flow Metab ; 18(4): 345-8, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9538898

RESUMEN

Hepatocyte growth factor (HGF), a natural ligand for the c-met protooncogene product, exhibits mitogenic, motogenic, and morphogenic activities for regeneration of the liver, kidney, and lung. Recently, HGF was clearly shown to enhance neurite outgrowth in vitro. To determine whether HGF has a neuroprotective action against the death of neurons in vivo, we studied the effect of HGF on delayed neuronal death in the hippocampus after 5-minute transient forebrain ischemia in Mongolian gerbils. Continuous postischemic intrastriatal administration of human recombinant HGF (10 or 30 micrograms) for 7 days potently prevented the delayed death of hippocampal neurons under both anesthetized and awake conditions. Even when HGF infusion started 6 hours after ischemia (i.e., in a delayed manner), HGF exhibited a neuroprotective action. We conclude that HGF, a novel neurotrophic factor, has a profound neuroprotective effect against postischemic delayed neuronal death in the hippocampus, which may have implications for the development of new therapeutic strategies for ischemic neuronal damage in humans.


Asunto(s)
Apoptosis/efectos de los fármacos , Isquemia Encefálica/tratamiento farmacológico , Factor de Crecimiento de Hepatocito/uso terapéutico , Hipocampo/efectos de los fármacos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Animales , Isquemia Encefálica/patología , Hipoxia de la Célula , Células Cultivadas , Cuerpo Estriado , Gerbillinae , Factor de Crecimiento de Hepatocito/farmacología , Hipocampo/irrigación sanguínea , Hipocampo/patología , Humanos , Masculino , Fármacos Neuroprotectores/farmacología , Proteínas Recombinantes/farmacología , Proteínas Recombinantes/uso terapéutico
3.
Nihon Geka Gakkai Zasshi ; 98(10): 880-3, 1997 Oct.
Artículo en Japonés | MEDLINE | ID: mdl-9423196

RESUMEN

Japanese people are covered with comprehensive national health-care insurance system since 1960's. Recently, elderly people have increased rapidly and healthcare cost for them has reached to share 30% in national health care expenditure. Several innovative reforms in healthcare system are now carried out. Legal price of drugs which has been fixed in social insurance, shall be floated in market mechanism, and payment system will be changed from "fee for services" to "per case system" like DRG/PPS. New health insurance scheme for the elderly is to be introduced in near future.


Asunto(s)
Atención a la Salud , Reforma de la Atención de Salud , Programas Nacionales de Salud , Costos de la Atención en Salud , Humanos , Japón
4.
Am J Physiol ; 270(6 Pt 1): L1031-9, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8764230

RESUMEN

Hepatocyte growth factor (HGF) has mitogenic, morphogenic, and motogenic activities on epithelial cells and plays important roles in regeneration of the liver and the kidney. We previously found that the expression of HGF gene is rapidly induced in the lung after acute lung injury in experimental animals and that HGF levels are elevated in blood of patients with lung diseases. To search for a possible pulmotrophic function of HGF in lung regeneration, we examined the mitogenic activity of HGF on tracheal epithelial cells in vitro and evaluated the efficacy of HGF-administration on lung regeneration after acute lung injury in mice. HGF markedly stimulated proliferation and DNA synthesis of rat tracheal epithelial cells in primary culture in a dose-dependent manner. The intravenous injection of human recombinant HGF (10 micrograms.mouse-1.day-1) into mice with acute lung injury induced by the intratracheal infusion of 10 mM HCI stimulated DNA synthesis of airway epithelial cells to levels threefold higher than those in mice with no HGF-injections, but it did not stimulate DNA synthesis of alveolar epithelial cells. However, HGF injection at higher dose (100 micrograms.mouse-1.day-1) stimulated DNA synthesis of alveolar epithelial cells in vivo. These results indicate that HGF is a potent mitogen for airway epithelial cells and alveolar epithelial cells in vivo as well as in vitro. HGF may act as pulmotrophic factor responsible for airway and alveolar regeneration during lung regeneration after acute lung injury.


Asunto(s)
Factor de Crecimiento de Hepatocito/farmacología , Pulmón/citología , Pulmón/efectos de los fármacos , Mitógenos/farmacología , Regeneración/fisiología , Animales , División Celular/efectos de los fármacos , Células Cultivadas , ADN/biosíntesis , Células Epiteliales , Epitelio/efectos de los fármacos , Epitelio/fisiología , Humanos , Pulmón/fisiología , Masculino , Ratones , Ratones Endogámicos ICR , Ratas , Proteínas Recombinantes , Tráquea/citología , Tráquea/efectos de los fármacos
5.
Cancer Chemother Pharmacol ; 38 Suppl: S42-7, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8765416

RESUMEN

Hepatocyte growth factor (HGF), a ligand for Met tyrosine kinase, is a mesenchyme- or stroma-derived multipotent factor that regulates the growth, motility, and morphogenesis of various types of cells. During lung development, Met/HGF receptor mRNA was localized in lung epithelial cells, whereas HGF mRNA was localized in lung mesenchymal cells in rat embryos. Antisense HGF oligonucleotides specifically inhibited epithelial branching morphogenesis in cultured lung rudiment isolated from day-13 rat embryos, whereas recombinant HGF stimulated branching morphogenesis. Thus, HGF seems to be at least one of the mesenchyme-derived factors that support branching morphogenesis during lung development. Together with the finding that HGF plays important roles in organogenesis and morphogenesis of organs such as the liver and kidney, HGF seems to be a mediator in epithelium-mesenchyme interactions during organogenesis. Extending the conceptual framework of epithelium-mesenchyme (or epithelium-stroma) interactions, we next examined the possible involvement of HGF in tumor-stroma interactions, because the growth and motility of carcinoma cells are regulated through their interactions with host stromal cells. HGF induced in vitro migration and invasion of GB-d1 gallbladder carcinoma cells into basement membrane components and collagen-gel matrix; however, several other growth factors did not induce marked migration and invasion of the carcinoma cells. GB-d1 cells do not produce HGF, but they produce in inducing factor for HGF production in fibroblasts; the inducing molecule was identified as interleukin 1 beta. Cocultivation of GB-d1 cells with stromal fibroblasts embedded in a collagen-gel matrix induced invasion of GB-d1 cells into the collagen gels, but invasion was inhibited by a specific antibody against HGF. This indicates that in vitro invasion of GB-d1 cells depends on stromal fibroblasts and that the fibroblast-derived invasion factor is HGF. Since HGF stimulated in vitro migration and invasion of various carcinoma cells and several carcinoma cells produced inducing factors for HGF production in stromal fibroblasts, the looped interaction of carcinoma cells and stromal fibroblasts mediated by HGF and HGF inducers may be a mechanism responsible for acquisition of the malignant phenotype through tumor-stroma interactions.


Asunto(s)
Factor de Crecimiento de Hepatocito/fisiología , Pulmón/crecimiento & desarrollo , Células Tumorales Cultivadas/fisiología , Animales , Epitelio/fisiología , Fibroblastos/fisiología , Humanos , Mesodermo/fisiología , Morfogénesis , Células del Estroma/fisiología
7.
Nihon Koshu Eisei Zasshi ; 41(8): 671-81, 1994 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-7949279

RESUMEN

Presently in Japan, care for the aged who are bedridden, afflicted with dementia or other conditions, is provided by hospitals, skilled nursing homes (providing a certain amount of medical care) and special nursing homes (for those needing ADL assistance). Facilities for long term care of the aged are insufficient, and there are many problems in matching care needs to the services supplied in these facilities. In October 1990, a survey was conducted to collect data for helping define the optimum services needed for the aged in long term care facilities. The subjects consisted of 1,262 persons in 12 facilities: 314 in three general hospitals (average age: 78.5); 391 in three hospitals for the aged (80.8); 410 in four skilled nursing homes (81.2); 147 in two special nursing homes (81.3). Results of the survey are as follows: 1. The proportion of "seriously demented" and "very seriously demented" subjects, (according to Karasawa's scale.), was 17.5% in general hospitals, 28.7% in hospitals for the aged, 16.4% in skilled nursing homes, and 22.6% in special nursing homes. 2. For ADL, "mobility" with whole assistance was required for 40.5% of the subjects in general hospitals, 58.7% in hospitals for the aged, 22.9% in skilled nursing homes, and 37.5% in special nursing homes. 3. During the month preceding the survey, medical examinations were conducted on 98.4% in general hospitals, 99.5% in hospitals for the aged, 23.0% in skilled nursing homes, and 59.4% in special nursing homes. These examinations consisted mostly of urine and blood analyses. ECGs and x-ray tests were also performed on more than 70% of subjects in the two types of hospitals.


Asunto(s)
Instituciones de Salud , Servicios de Salud para Ancianos , Actividades Cotidianas , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Japón , Cuidados a Largo Plazo , Masculino , Casas de Salud
11.
Jpn Heart J ; 17(3): 326-37, 1976 May.
Artículo en Inglés | MEDLINE | ID: mdl-948112

RESUMEN

Twenty-eight goats with an artificial heart (AH) were studied pathologically. Being continued from the previous report, the liver, gastrointestinal tract, and kidneys were taken up in this paper and finally, general discussion was done to get our ideas in shape concerning the pathophysiological status of the goat. Central necrosis of the liver was always observed in the goats which survived for over 140 hours. This finding seemed to be caused mainly by circulatory insufficiency of the portal vein at the latter half of the survival time. Microscopic findings of degeneration, necrosis, and edema were commonly observed at the walls of gastrointestinal tracts, when goats showed poor apetite, mucous feces and constipation. But these problems have been improved by application of a new control method to regulate the output of AH system within a goat's physiological range since October 1974. The lesions seen in the kidneys are classified into 5 groups. The most important findings of them are lower nephron nephrosis and cortical necrosis, both of which indicate the occurrence of long standing vasoconstriction of proximal renal arteries. By means of microangiographic method and others, thrombi were detected frequently in the kidneys. The vascular walls, where thrombi were attached to, were often damaged. Therefore, these thrombi were thought to be formed in the local vessels in situ through renal circulatory insufficiency. The renal pathological lesions have been also improved and severe renal failure from which the previous goats could not escape, has been lessened since the application of a new AH control method. As a whole, the main pathophysiological status of the animals replaced by the AH are thought conclusively to be peripheral circulatory insufficiency. This would be caused by abnormal hemodynamics, so that, the essential clinical etiology is thought to be AH function itself.


Asunto(s)
Sistema Digestivo/patología , Corazón Artificial/efectos adversos , Riñón/patología , Hígado/patología , Complicaciones Posoperatorias/patología , Animales , Ascitis/patología , Sistema Digestivo/irrigación sanguínea , Hígado Graso/patología , Cabras , Corazón Artificial/mortalidad , Infarto/patología , Perforación Intestinal/patología , Necrosis , Tamaño de los Órganos , Sistema Porta/patología , Arteria Renal/patología , Trombosis/patología
12.
Jpn Heart J ; 17(2): 233-45, 1976 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-933361

RESUMEN

Pathological studies using routine pathological technics, microangiography and electron microscopy were performed on the 28 goats with an artificial heart (including 2 goats which survived for 30 and 37 days). In this paper, the brain, natural heart, and lungs of the goats were discussed. No special findings were seen in the brain except for rare infarcted areas. The natural heart almost always showed infarction-like lesions in the sub-endocardium and myocardium at the cut surface. The longer the animal survive, these findings became the more serious. The light microscopic findings on the lungs were classified into 6 groups. The most important findings of them are massive, diffuse exsudation with hemorrhage and its changes to chronic status. The main pathophysiological status, causing the pulmonary lesions, seemed to be peripheral circulatory insufficiency with increased permeability of peripheral vessels, especially of venulae. Thrombi were detected more frequently in the kidneys and lungs than in any other organs. The vascular walls where the thrombi were attached to, where often seen to be damaged, so that almost all thrombi were thought to be formed in the local vessels in situ, but not in the artificial heart. The main clinical causes to the pulmonary insufficiency were thought to be surgical operation including anesthesia, functional incompleteness of the artificial heart, etc.


Asunto(s)
Cabras , Corazón Artificial , Tromboembolia/patología , Angiografía , Animales , Encéfalo/patología , Procedimientos Quirúrgicos Cardíacos , Pulmón/patología , Pulmón/ultraestructura , Miocardio/patología , Complicaciones Posoperatorias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA